Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simon J Draper

Showing results (71-80 of 165) with videos related to

Pageof 17
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 11, 2022
Modular capsid decoration boosts adenovirus vaccine-induced humoral immunity against SARS-CoV-2Matthew D J Dicks, Louisa M Rose, Rebecca A Russell, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2008
In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccinationJagadeesh Bayry, Elma Z Tchilian, Matthew N Davies, et al.
Nature|August 19, 2014
Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodiesKatherine E Wright, Kathryn A Hjerrild, Jonathan Bartlett, et al.
Plos One|April 4, 2012
Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primatesAlexandra J Spencer, Fergal Hill, Jared D Honeycutt, et al.
Vaccine|December 1, 2015
Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoterNaif Khalaf Alharbi, Alexandra J Spencer, Ahmed M Salman, et al.
Scientific Reports|July 18, 2020
Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinationsYvonne Azasi, Shannon K Gallagher, Ababacar Diouf, et al.
Msphere|August 11, 2021
Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike GlycoproteinRobert J Ragotte, David Pulido, Francesca R Donnellan, et al.
BMC Infectious Diseases|August 25, 2017
Plasmodium falciparum malaria parasite var gene expression is modified by host antibodies: longitudinal evidence from controlled infections of Kenyan adults with varying natural exposureAbdirahman I Abdi, Susanne H Hodgson, Michelle K Muthui, et al.
Malaria Journal|December 4, 2023
Human monoclonal antibodies inhibit invasion of transgenic Plasmodium knowlesi expressing Plasmodium vivax Duffy binding proteinQuentin D Watson, Lenore L Carias, Alyssa Malachin, et al.
Vaccine|May 4, 2024
Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine developmentJonas E Mertens, Cassandra A Rigby, Martino Bardelli, et al.
Pageof 17

Showing results (71-80 of 165) with videos related to

Sort By:
Pageof 17
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 11, 2022
Modular capsid decoration boosts adenovirus vaccine-induced humoral immunity against SARS-CoV-2Matthew D J Dicks, Louisa M Rose, Rebecca A Russell, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 16, 2008
In silico identified CCR4 antagonists target regulatory T cells and exert adjuvant activity in vaccinationJagadeesh Bayry, Elma Z Tchilian, Matthew N Davies, et al.
Nature|August 19, 2014
Structure of malaria invasion protein RH5 with erythrocyte basigin and blocking antibodiesKatherine E Wright, Kathryn A Hjerrild, Jonathan Bartlett, et al.
Plos One|April 4, 2012
Fusion of the Mycobacterium tuberculosis antigen 85A to an oligomerization domain enhances its immunogenicity in both mice and non-human primatesAlexandra J Spencer, Fergal Hill, Jared D Honeycutt, et al.
Vaccine|December 1, 2015
Enhancing cellular immunogenicity of MVA-vectored vaccines by utilizing the F11L endogenous promoterNaif Khalaf Alharbi, Alexandra J Spencer, Ahmed M Salman, et al.
Scientific Reports|July 18, 2020
Bliss' and Loewe's additive and synergistic effects in Plasmodium falciparum growth inhibition by AMA1-RON2L, RH5, RIPR and CyRPA antibody combinationsYvonne Azasi, Shannon K Gallagher, Ababacar Diouf, et al.
Msphere|August 11, 2021
Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike GlycoproteinRobert J Ragotte, David Pulido, Francesca R Donnellan, et al.
BMC Infectious Diseases|August 25, 2017
Plasmodium falciparum malaria parasite var gene expression is modified by host antibodies: longitudinal evidence from controlled infections of Kenyan adults with varying natural exposureAbdirahman I Abdi, Susanne H Hodgson, Michelle K Muthui, et al.
Malaria Journal|December 4, 2023
Human monoclonal antibodies inhibit invasion of transgenic Plasmodium knowlesi expressing Plasmodium vivax Duffy binding proteinQuentin D Watson, Lenore L Carias, Alyssa Malachin, et al.
Vaccine|May 4, 2024
Evaluation of the precision of the Plasmodium knowlesi growth inhibition assay for Plasmodium vivax Duffy-binding protein-based malaria vaccine developmentJonas E Mertens, Cassandra A Rigby, Martino Bardelli, et al.
Pageof 17